Review article · 2025 · Open access

Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution

Xin Xu, Lili Cui, Yong Zhang, Jingkai Gu

Acta Pharmaceutica Sinica B, 16(4), 1943–1970 · Published 20 November 2025 · DOI 10.1016/j.apsb.2025.11.023

Open full textCite this paper

In brief

“Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution” is a 2025 review article by Xin Xu and 3 co-authors, published in Acta Pharmaceutica Sinica B. OpenAlex counts 23 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Acta Pharmaceutica Sinica B.

Citations
23
Most cited in
2026 (23)
Field-weighted impact
1.34
References
280
Authors
4

Abstract

The remarkable clinical success of mRNA-lipid nanoparticle (mRNA-LNP) vaccines, particularly evidenced by their pandemic-era impact and subsequent 2023 Nobel Prize recognition, has intensified global efforts to expand their application toward therapeutic biologics. Despite showing strong preventive effects, there are still fundamental knowledge gaps in comprehensively defining the hierarchical biological trajectory of mRNA-LNP formulations, which spans from initial systemic exposure, tissue-specific biodistribution, and intracellular delivery to ultimate protein expression dynamics. These unresolved mechanistic questions pose significant constraints on the rational design of next-generation mRNA-LNP therapeutics, which face increased demands for precision dosing, therapeutic efficacy optimization, and enhanced safety profiles. This review discusses the in vivo fate of mRNA-LNP, focusing specifically on blood/tissue/cellular distribution and kinetics/exposure profiles of both intact mRNA-LNP and dissociated components post-administration. It discusses key factors influencing the distribution of expressed protein and summarizes the corresponding research toolkits along with their advantages and disadvantages. Additionally, it compiles strategies to enhance delivery efficacy, tissue tropism, and safety profiles of mRNA-LNP. We anticipate a better understanding of the biological processes and dynamic pattern of mRNA-LNP, which will accelerate the development of next-generation mRNA biologics with predictable safety and delivery efficiency. Systematically characterizing the biological fate of mRNA-LNPs, from initial systemic exposure to tissue-specific biodistribution and intracellular delivery, and ultimately to protein expression dynamics, may benefit the rational development of next-generation mRNA-LNP therapeutics.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Xu, X., Cui, L., Zhang, Y., & Gu, J. (2025). Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution. Acta Pharmaceutica Sinica B, 16(4), 1943–1970. https://doi.org/10.1016/j.apsb.2025.11.023

MLA 9

Xu, Xin, et al. “Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution.” Acta Pharmaceutica Sinica B, vol. 16, no. 4, 2025, pp. 1943–1970. https://doi.org/10.1016/j.apsb.2025.11.023.

Chicago

Xu, Xin, Lili Cui, Yong Zhang, and Jingkai Gu. 2025. “Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution.” Acta Pharmaceutica Sinica B 16 (4): 1943–1970. https://doi.org/10.1016/j.apsb.2025.11.023.

Harvard

Xu, X. et al. (2025) ‘Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution’, Acta Pharmaceutica Sinica B, 16(4), pp. 1943–1970. doi:10.1016/j.apsb.2025.11.023.

IEEE

X. Xu, L. Cui, Y. Zhang, and J. Gu, “Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution,” Acta Pharmaceutica Sinica B, vol. 16, no. 4, pp. 1943–1970, 2025, doi: 10.1016/j.apsb.2025.11.023.

BibTeX

@article{xu2025deciphering,
  title     = {{Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution}},
  author    = {Xu, Xin and Cui, Lili and Zhang, Yong and Gu, Jingkai},
  journal   = {Acta Pharmaceutica Sinica B},
  year      = {2025},
  volume    = {16},
  number    = {4},
  pages     = {1943--1970},
  doi       = {10.1016/j.apsb.2025.11.023},
  url       = {https://doi.org/10.1016/j.apsb.2025.11.023}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • mRNA lipid nanoparticles
  • mRNA therapeutics
  • tissue distribution
  • intracellular delivery
  • protein expression dynamics
  • tissue tropism
  • treatment safety
  • mRNA vaccines

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Xu, X., Cui, L., Zhang, Y., & Gu, J. (2025). Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution. Acta Pharmaceutica Sinica B, 16(4), 1943–1970. https://doi.org/10.1016/j.apsb.2025.11.023

How many times has this paper been cited?

23 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Acta Pharmaceutica Sinica B: sign in and open the full text from this page.

Who wrote this paper?

Xin Xu, Lili Cui, Yong Zhang, Jingkai Gu.

What is the DOI of this paper?

10.1016/j.apsb.2025.11.023, permanently at https://doi.org/10.1016/j.apsb.2025.11.023. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.